DAFNA Capital Management LLC Diversified Active

Location: Los Angeles, CA

CIK: 0001389933 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value: $118M (95.3% shares, 4.7% debt)

Holdings (72)

LOXO ONCOLOGY INC 10.7%
Value $12.65M Shares 300,722 Est. Cost $34.29 Unrealized
ATRC ATRICURE INC 8.2%
Value $9.708M Shares 506,946 Est. Cost $12.11 Unrealized +44.6%
NXSTAGE MEDICAL INC 4.9%
Value $5.798M Shares 216,119 Est. Cost $12.97 Unrealized
ALDER BIOPHARMACEUTICALS INC 3.9%
Value $4.597M Shares 221,013 Est. Cost $24.29 Unrealized
BCRX BIOCRYST PHARMACEUTICALS INC 3.8%
Value $4.545M Shares 541,128 Est. Cost $6.74 Unrealized +3.2%
SUNESIS PHARMACEUTICALS INC 3.0%
Value $3.557M Shares 867,529 Est. Cost $3.62 Unrealized
BLUEPRINT MEDICINES CORP 2.8%
Value $3.299M Shares 82,500 Est. Cost $29.50 Unrealized
GLPG GALAPAGOS NV 2.6%
Value $3.048M Shares 35,359 Est. Cost $51.40 Unrealized
ONC BEIGENE LTD 2.5%
Value $2.974M Shares 81,231 Est. Cost $30.44 Unrealized
APPLIED GENETIC TECHNOL CORP 2.4%
Value $2.836M Shares 411,000 Est. Cost $12.32 Unrealized
ARDX ARDELYX INC 2.4%
Value $2.805M Shares 221,738 Est. Cost $10.99 Unrealized +19.8%
PODD INSULET CORP 2.3%
Value $2.736M Shares 63,484 Est. Cost $28.33 Unrealized +51.4%
AEGLEA BIOTHERAPEUTICS INC 2.2%
Value $2.61M Shares 350,392 Est. Cost $4.86 Unrealized
IBB ISHARES TR NASDQ BIOTEC 2.2%
Value $2.551M Shares 8,700 Est. Cost $265.40 Unrealized
INSULET CORP 2.1%
Value $2.537M Shares 2,250,000 Est. Cost $1.11 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 2.1%
Value $2.533M Shares 58,508 Est. Cost $39.85 Unrealized +7.5%
MGNX MACROGENICS INC 1.9%
Value $2.217M Shares 119,200 Est. Cost $23.38 Unrealized -17.5%
BIOTELEMETRY INC 1.8%
Value $2.171M Shares 75,000 Est. Cost $9.68 Unrealized
AERIE PHARMACEUTICALS INC 1.8%
Value $2.121M Shares 46,770 Est. Cost $21.66 Unrealized
PROTALIX BIOTHERAPEUTICS INC 1.7%
Value $1.963M Shares 2,500,000 Est. Cost $0.80 Unrealized
SPECTRANETICS CORP 1.6%
Value $1.908M Shares 65,496 Est. Cost $15.23 Unrealized
RADIUS HEALTH INC 1.6%
Value $1.886M Shares 48,809 Est. Cost $33.51 Unrealized
CLLS CELLECTIS S A 1.6%
Value $1.834M Shares 76,404 Est. Cost $24.00 Unrealized
CARA THERAPEUTICS INC 1.5%
Value $1.753M Shares 95,322 Est. Cost $11.32 Unrealized
IMMUNOMEDICS INC 1.4%
Value $1.634M Shares 252,574 Est. Cost $2.32 Unrealized
CIDARA THERAPEUTICS INC 1.4%
Value $1.626M Shares 208,458 Est. Cost $9.79 Unrealized
FOAMIX PHARMACEUTICALS LTD 1.4%
Value $1.612M Shares 325,667 Est. Cost $7.19 Unrealized
RIGEL PHARMACEUTICALS INC 1.3%
Value $1.567M Shares 473,478 Est. Cost $3.31 Unrealized
ADVAXIS INC 1.2%
Value $1.405M Shares 172,000 Est. Cost $7.16 Unrealized
XENE XENON PHARMACEUTICALS INC 1.1%
Value $1.358M Shares 339,614 Est. Cost $7.82 Unrealized +0.6%
QURE UNIQURE NV 1.0%
Value $1.179M Shares 203,907 Est. Cost $13.39 Unrealized -55.1%
JNJ JOHNSON AND JOHNSON 1.0%
Value $1.171M Shares 9,400 Est. Cost $59.66 Unrealized +56.5%
SCYNEXIS INC 0.9%
Value $1.054M Shares 381,900 Est. Cost $4.26 Unrealized
NEURODERM LTD 0.8%
Value $994K Shares 37,438 Est. Cost $19.86 Unrealized
BIOLINERX LTD 0.8%
Value $961K Shares 1,000,000 Est. Cost $0.96 Unrealized
DERMIRA INC 0.8%
Value $955K Shares 28,000 Est. Cost $21.64 Unrealized
VYGR VOYAGER THERAPEUTICS INC 0.8%
Value $944K Shares 71,320 Est. Cost $13.24 Unrealized
SYNERON MEDICAL LTD 0.8%
Value $907K Shares 85,947 Est. Cost $8.70 Unrealized
TANDEM DIABETES CARE INC 0.7%
Value $869K Shares 724,286 Est. Cost $7.86 Unrealized
ARQULE INC 0.7%
Value $855K Shares 807,008 Est. Cost $1.23 Unrealized
ACHILLION PHARMACEUTICALS 0.7%
Value $827K Shares 196,500 Est. Cost $9.91 Unrealized
MINERVA NEUROSCIENCES INC 0.7%
Value $821K Shares 101,317 Est. Cost $8.10 Unrealized
BLUEBIRD BIO INC 0.7%
Value $818K Shares 9,000 Est. Cost $46.68 Unrealized
EXACTECH INC 0.7%
Value $797K Shares 31,636 Est. Cost $19.74 Unrealized
STXS STEREOTAXIS INC 0.7%
Value $782K Shares 1,372,862 Est. Cost $2.92 Unrealized -78.5%
CASCADIAN THERAPEUTICS INC 0.6%
Value $767K Shares 185,259 Est. Cost $4.14 Unrealized
NOVADAQ TECHNOLOGIES INC 0.6%
Value $747K Shares 95,841 Est. Cost $13.46 Unrealized
IRONWOOD PHARMACEUTICALS INC 0.6%
Value $714K Shares 573,000 Est. Cost $1.03 Unrealized
NEOS THERAPEUTICS INC 0.6%
Value $686K Shares 95,273 Est. Cost $12.83 Unrealized
ZOGENIX INC 0.5%
Value $649K Shares 59,778 Est. Cost $5.87 Unrealized
AKBA AKEBIA THERAPEUTICS INC 0.5%
Value $648K Shares 70,455 Est. Cost $9.76 Unrealized 0.0%
COGENTIX MEDICAL INC 0.5%
Value $636K Shares 353,482 Est. Cost $1.68 Unrealized
GEMPHIRE THERAPEUTICS INC 0.5%
Value $554K Shares 52,797 Est. Cost $10.49 Unrealized
ASND ASCENDIS PHARMA 0.4%
Value $510K Shares 18,214 Est. Cost $18.57 Unrealized
INOTEK PHARMACEUTICALS CORP 0.4%
Value $474K Shares 237,135 Est. Cost $9.48 Unrealized
EIGER BIOPHARMACEUTICALS INC 0.3%
Value $412K Shares 35,977 Est. Cost $13.39 Unrealized
SIERRA ONCOLOGY INC 0.3%
Value $405K Shares 265,000 Est. Cost $1.53 Unrealized
CYMABAY THERAPEUTICS INC COM 0.3%
Value $379K Shares 88,067 Est. Cost $4.30 Unrealized
INOTEK PHARMACEUTICALS CORP 0.3%
Value $372K Shares 600,000 Est. Cost $1.32 Unrealized
ABEONA THERAPEUTICS INC 0.3%
Value $338K Shares 67,537 Est. Cost $4.84 Unrealized
CELYAD 0.3%
Value $328K Shares 12,528 Est. Cost $23.63 Unrealized
MASI MASIMO CORPORATION 0.3%
Value $326K Shares 3,500 Est. Cost $23.74 Unrealized +246.8%
OBSEVA SA 0.2%
Value $260K Shares 25,000 Est. Cost $10.40 Unrealized
BELLICUM PHARMACEUTICALS INC 0.2%
Value $247K Shares 20,000 Est. Cost $12.35 Unrealized
AXSM AXSOME THERAPEUTICS INC 0.2%
Value $217K Shares 55,700 Est. Cost $4.78 Unrealized 0.0%
AFFIMED THERAPEUTICS BV 0.2%
Value $213K Shares 92,500 Est. Cost $2.30 Unrealized
PIERIS PHARMACEUTICALS INC 0.1%
Value $139K Shares 53,525 Est. Cost $1.67 Unrealized
ADAMIS PHARMACEUTICALS CORP 0.1%
Value $128K Shares 30,000 Est. Cost $4.27 Unrealized
ANAB ANAPTYSBIO INC 0.1%
Value $125K Shares 4,500 Est. Cost $23.32 Unrealized 0.0%
TONIX PHARMACEUTICALS HLDG C 0.1%
Value $93,000 Shares 20,000 Est. Cost $4.65 Unrealized
BIOPHARMX CORP 0.0%
Value $58,000 Shares 115,000 Est. Cost $0.42 Unrealized
GALENA BIOPHARMA INC COM NEW 0.0%
Value $28,000 Shares 46,145 Est. Cost $0.61 Unrealized